| Interleukin-1 family cytokines: keystones in liver inflammatory diseases L Barbier, M Ferhat, E Salamé, A Robin, A Herbelin, JM Gombert, ... Frontiers in immunology 10, 2014, 2019 | 122 | 2019 |
| Autophagy in adipose tissue physiology and pathophysiology M Ferhat, K Funai, S Boudina Antioxidants & Redox Signaling 31 (6), 487-501, 2019 | 86 | 2019 |
| Autophagy ablation in adipocytes induces insulin resistance and reveals roles for lipid peroxide and Nrf2 signaling in adipose-liver crosstalk J Cai, KM Pires, M Ferhat, B Chaurasia, MA Buffolo, R Smalling, ... Cell reports 25 (7), 1708-1717. e5, 2018 | 81 | 2018 |
| Endogenous IL-33 contributes to kidney ischemia-reperfusion injury as an alarmin M Ferhat, A Robin, S Giraud, S Sena, JM Goujon, G Touchard, T Hauet, ... Journal of the American Society of Nephrology 29 (4), 1272-1288, 2018 | 71 | 2018 |
| Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue T Fali, T Aychek, M Ferhat, JY Jouzeau, M Busslinger, D Moulin, G Eberl Mucosal Immunology 14 (3), 585-593, 2021 | 32 | 2021 |
| The impact of invariant NKT cells in sterile inflammation: the possible contribution of the alarmin/cytokine IL-33 MH Ferhat, A Robin, L Barbier, A Thierry, JM Gombert, A Barbarin, ... Frontiers in Immunology 9, 2308, 2018 | 30 | 2018 |
| Late‐in‐life treadmill training rejuvenates autophagy, protein aggregate clearance, and function in mouse hearts JM Cho, SK Park, R Ghosh, K Ly, C Ramous, L Thompson, M Hansen, ... Aging Cell 20 (10), e13467, 2021 | 15 | 2021 |
| Identification of a paracrine signaling mechanism linking CD34high progenitors to the regulation of visceral fat expansion and remodeling M Buffolo, KM Pires, M Ferhat, O Ilkun, A Makaju, A Achenbach, ... Cell Reports 29 (2), 270-282. e5, 2019 | 14 | 2019 |
| BMPER is a marker of adipose progenitors and adipocytes and a positive modulator of adipogenesis JD Garritson, J Zhang, A Achenbach, M Ferhat, E Eich, CJ Stubben, ... Communications Biology 6 (1), 638, 2023 | 6 | 2023 |
| Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis J Hablot, M Ferhat, A Lavelle, F Salem, M Taieb, J Medvedovic, N Kindt, ... Clinical and Translational Medicine 10 (5), 2020 | 5 | 2020 |
| IL-33 receptor ST2 deficiency attenuates renal ischaemia–reperfusion injury in euglycaemic, but not streptozotocin-induced hyperglycaemic mice M Sehnine, M Ferhat, S Sena, JM Gombert, JM Goujon, A Thierry, ... Diabetes & metabolism 44 (1), 55-60, 2018 | 4 | 2018 |
| Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs M Ferhat, J Hablot, M Taieb, F Salem, P Netter, L Peyrin‐Biroulet, ... Clinical and Translational Medicine 11 (6), 2021 | 3 | 2021 |
| Interleukin-1 family cytokines: keystones in liver inflammatory diseases. Front Immunol. 2019; 10: 2014 L Barbier, M Ferhat, E Salamé, A Robin, A Herbelin, JM Gombert, ... | 3 | 2014 |
| Ischemia-reperfusion injury after kidney transplantation L Dufour, M Ferhat, A Robin, S Inal, F Favreau, JM Goujon, T Hauet, ... Néphrologie & Thérapeutique 16 (6), 388-399, 2020 | 2 | 2020 |
| Late‐In‐Life Treadmill‐Training Ameliorates the Decline in Cardiac Autophagy Associated with Aging in Mice JM Cho, C Ramous, MS Mattera, M Hansen, KM Pires, M Ferhat, ... The FASEB Journal 33 (S1), 693.4-693.4, 2019 | 1 | 2019 |
| The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of … M Ferhat, K Mangano, I Mirkina, J Mayer, G Rossmueller, A Schinagl, ... European Journal of Pharmacology 956, 175997, 2023 | | 2023 |
| # 6547 ON104, A NOVEL BIOENGINEERED ANTIBODY TARGETING OXIDIZED MACROPHAGE MIGRATION INHIBITORY FACTOR (OXMIF) AMELIORATES EXPERIMENTAL GLOMERULONEPHRITIS M Ferhat, R Kerschbaumer, F Tam, M Prendecki, L Costa, M Thiele, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_6547, 2023 | | 2023 |
| ON104, a novel antibody targeting oxidized Macrophage Migration Inhibitory Factor (oxMIF) shows efficacy in preclinical models of chronic inflammation M Ferhat, C Landlinger, R Kerschbaumer, FWK Tam, F Nicoletti, M Thiele The Journal of Immunology 210 (1_Supplement), 85.02-85.02, 2023 | | 2023 |
| Targeting Oxidized Macrophage Migration Inhibitory Factor (oxMIF)-a Novel Treatment Approach for Rheumatoid Arthritis C Landlinger, M Ferhat, F Nicoletti, M Thiele ARTHRITIS & RHEUMATOLOGY 74, 617-618, 2022 | | 2022 |
| Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs J Hablot, M Ferhat, M Taieb, F Salem, P Netter, L Peyrin-Biroulet, ... FUNDAMENTAL & CLINICAL PHARMACOLOGY 36, 46-47, 2022 | | 2022 |
